Balance Sheet

Accounts Payables Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Sanofi (SNY) Liabilities from Discontinued Operations (2024 - 2025)

Sanofi's Liabilities from Discontinued Operations history spans 2 years, with the latest figure at 2263919.38 for Q2 2025.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 2263919.38 in Q2 2025 year-over-year; TTM through Jun 2025 was 2263919.38, a N/A change, with the full-year FY2024 number at 2277176797.75, changed N/A from a year prior.
Liabilities from Discontinued Operations hit 2263919.38 in Q2 2025 for Sanofi, down from 2277176797.75 in the prior quarter.
Over the last five years, Liabilities from Discontinued Operations for SNY hit a ceiling of 2277176797.75 in Q4 2024 and a floor of 2263919.38 in Q2 2025.